Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calcium antagonists and atherosclerosis.

E Betz1, H D Weiss, H Heinle

  • 1Institute of Physiology (I), University of Tübingen, Germany.

Journal of Cardiovascular Pharmacology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of the adenosine triphosphate-sensitive potassium channels in pinacidil-induced vasodilatation of the human saphenous vein in patients with and without type 2 diabetes mellitus.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2020
Same author

Effects of the polyphenol resveratrol on contractility of human term pregnant myometrium.

Molecular human reproduction·2015
Same author

The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K(+) channels.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2014
Same author

Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin.

Life sciences·2013
Same author

The novel phenylpropiophenone derivates induced relaxation of isolated rat aorta.

Arzneimittel-Forschung·2012
Same author

The low-dose combination preparation Vertigoheel activates cyclic nucleotide pathways and stimulates vasorelaxation.

Clinical hemorheology and microcirculation·2010
Same journal

Imipramine Can Block Human Cardiac H1-Histamine Receptors.

Journal of cardiovascular pharmacology·2026
Same journal

Ivabradine in the Treatment of POTS Before and After COVID-19 Pandemic: A Systematic Review and Meta-Analysis.

Journal of cardiovascular pharmacology·2026
Same journal

Mineralocorticoid receptor antagonists in managing hypertension: a link with diurnal patterns of blood pressure.

Journal of cardiovascular pharmacology·2026
Same journal

The Cardiac Sarcomere: From development of heritable cardiomyopathies to gene and precision therapies.

Journal of cardiovascular pharmacology·2026
Same journal

Efficacy and Safety of Lorundrostat for Uncontrolled and Treatment-resistant Hypertension: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Journal of cardiovascular pharmacology·2026
Same journal

Safety and Efficacy of Lorundrostat in Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

Journal of cardiovascular pharmacology·2026
See all related articles

Calcium antagonists show promise in preventing atherosclerosis progression and reducing arterial plaque. These substances impact key mechanisms, including endothelial transport and cell proliferation, offering therapeutic potential.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Atherosclerosis Pathogenesis

Background:

  • Atherosclerosis is a chronic inflammatory disease characterized by plaque buildup in arteries.
  • Calcium plays a critical role in vascular smooth muscle contraction and endothelial function.
  • Existing research explores calcium's involvement in atheroma formation and progression.

Purpose of the Study:

  • To investigate the role of calcium antagonists in preventing atherosclerosis.
  • To explore the impact of calcium antagonists on intimal hyperplasia and calcium deposition.
  • To understand how calcium antagonists affect endothelial transport and cell proliferation in atherosclerosis.

Main Methods:

  • Review of numerous clinical trials and experimental models investigating calcium antagonists.

Related Experiment Videos

  • Analysis of studies focusing on transendothelial transport mechanisms.
  • In vitro studies using cell cultures from normal and atherosclerotic arteries.

    • Main Results:

    • Calcium antagonists demonstrate potential in inhibiting atherosclerosis genesis and progression.
    • These agents can influence atheroma calcification and intimal proliferation.
    • Transendothelial transport and endothelial cell functions are sensitive to various calcium antagonists.
    • Calcium antagonists can inhibit stenotic lesion development following arterial stimulation.

    Conclusions:

    • Calcium antagonists represent a potential therapeutic strategy for managing atherosclerosis.
    • Further research into the mechanisms of calcium antagonists is warranted for effective treatment.
    • Targeting calcium pathways offers a promising avenue for cardiovascular disease intervention.